No Intervention Drug,Active Comparator Drug

3 trials

Sponsors

Ramathibodi Hospital, Gastroenterological Association of Thailand, Faculty of Medicine, Thammasat University Hospital

Conditions

Dry eye condition in Diabetic mellitus type 2 patients undergoing cataract surgery (Phacoemulsification) Dry eye, Cataract surgery, Phacoemulsification, DiabetesVAP HAP Respiratory failure Sitafloxacin Intrapulmonary Critically ill patients Pneumonia Pharmacokineticsrenal impairment HBV viral control tenofovir dose reduction chronic hepatitis B renal impairment

Phase 2

Evaluation of preservative-free Hydroxypropyl methylcellulose with Dextran for Dry eye symptoms in Diabetic patient after Phacoemulsification Surgery

RecruitingTCTR20251003009

Faculty of Medicine, Thammasat University HospitalDry eye condition in Diabetic mellitus type 2 patients undergoing cataract surgery (Phacoemulsification) Dry eye, Cataract surgery, Phacoemulsification, Diabetes

Start: 2025-07-01Target: 60Updated: 2026-08-03

Phase 3

Comparison of viral control between two tenofovir dose reduction regimens (300 mg every 48 hours vs 300 mg every 72 hours) in chronic hepatitis B patients with moderate renal impairment from tenofovir induced renal dysfunction.

RecruitingTCTR20180207001

Gastroenterological Association of Thailandrenal impairment HBV viral control tenofovir dose reduction chronic hepatitis B renal impairment

Start: 2018-01-17Target: 108Updated: 2026-08-03

Unknown Phase

Intrapulmonary Penetration of Sitafloxacin and Treatment Outcomes in Thai Critically Ill Patients with Pneumonia

Active, not recruitingTCTR20170222001

Ramathibodi HospitalVAP HAP Respiratory failure Sitafloxacin Intrapulmonary Critically ill patients Pneumonia Pharmacokinetics

Start: 2017-03-15Target: 40Updated: 2026-08-03

Related Papers

Pharmacokinetics and Penetration of Sitafloxacin into Alveolar Epithelial Lining Fluid in Critically Ill Thai Patients with Pneumonia.

2019-09-238 citations